HomeHot Items Hot ItemsNews JPMorgan Bulls Appear In Options Land By option_review June 26, 2009 0 102 FacebookTwitterPinterestWhatsApp Today’s tickers: JPM, UPL, AMGN, STI, MRK, TLT, SNY, NKE, TIBX, VALE & ROST JPM – Option traders carousing in the August contract on JPM today appear cautiously optimistic on the stock amid a 0.5% rise in the underlying to $34.33. We observed some investors picking up 2,600 calls at the in-the-money August 34 strike price for 2.53 apiece and selling 2,800 calls at the higher August 40 strike for 56 cents each. Such transactions effectively create a trading range for the stock between the breakeven point on the purchased call options at $36.53 and $40.00. Put buying some 1,100 times at the August 34 strike for an average premium of 2.52 suggests caution by traders wary of potential bearish movement in the stock. Finally, those individuals looking for a roaring rally picked up 1,800 calls at the August 40 strike for 56 cents per contract. – JPMorgan Chase & Co. UPL – The independent oil and natural gas company jumped onto our ‘most active by options volume’ market scanner late this afternoon after one investor was seen drilling for options in the September contract. Shares of UPL are currently slightly lower by less than 0.5% to stand at $40.60 for the day. The trader appears to have funded the purchase of calls today by initiating a sold strangle strategy. The strangle involved the sale of 15,000 puts at the September 34 strike price for a premium of 1.61 apiece in combination with the sale of 15,000 calls at the September 46 strike for 1.91 per contract. The gross premium on the transaction amounts to 3.52. The third leg of the trade, likely funded with the proceeds of the strangle, involved the purchase of 10,000 calls at the in-the-money September 40 strike price for a hefty 4.48 each. The trader is looking for shares to make bullish moves by expiration, however, he does not want the stock to rise beyond the parameters of the strangle. – Ultra Petroleum Corp. AMGN – Two notable options plays on Amgen looked relatively bullish and suggest that an investor aims to defend a long position yet sees continued upside. First, using August puts a ratio combination wound up costing the investor a net 35 cent premium. The customer sold 20,000 August expiration puts to buy 10,000 puts at the higher 45 strike for a net debit of just 35 cents. In isolation the 45 puts would have cost 1.15. Sticking with the August contract the investor bought 10,000 calls at each of the 55 and 65 strikes at 2.05 and 25 cents respectively. Shares rebounded in April from a $45 low, which marks the 52-week low, while the upside call strikes would easily reap the benefit of a strong continuation of the nascent rally for shares of Amgen. – Amgen Inc. STI – Shares of the financial services company have slipped slightly by less than 1% to stand at $15.48 today. Options activity on the firm attracted our eye after one investor was seen enacting a bullish reversal on the company in the August contract. Hoping for a rally, this individual appears to have sold 10,000 puts short at the August 14 strike price for a premium of 1.00 apiece in order to finance the purchase of 10,000 calls at the higher August 17 strike price at a cost of 95 cents each. A credit of a nickel per contract is enjoyed by the trader who can expect to amass profits if the calls land in-the-money by expiration. Shares of STI would need to rally higher by approximately 10% by expiration in August. – SunTrust Banks, Inc. MRK– Certain activity by option traders populating MRK today suggests a potential range for the stock through expiration in August. The trades observed indicate that some investors are bullish on the stock. Such optimism could be a result of the positive opinion Merck received from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP). The committee recommended a restricted first line use of ‘Januvia’ to treat type 2 diabetes. Shares of the firm have responded positively by gaining about 1% to $26.80. The near-term July 27.5 strike price appears to have had 4,000 calls purchased for an average premium of 48 cents per contract. Investors long the calls will profit if the stock can rise 4% from the current price and break through $27.98 by expiration. Elsewhere, about 7,000 calls were sold short at the August 30 strike price for 26 cents each. One could postulate that the long call position in the July contract represents an effective lower range and the short sale of calls in August may provide an upper boundary for shares. The 26 cent premium enjoyed on the short sale will be fully retained as long as the August 30 calls land out-of-the-money by expiration. – Merck & Co., Inc. TLT – Following a week of successful note auctions by the U.S. government in which overseas central banks stepped up the pace, yields declined dramatically across the curve. The yield on the benchmark 10-year note for example, which recently poked its nose up at 4% yields shrank to 3.5% on Thursday. Bond prices are quiet today, yet one sizeable option trade occurred on the call side involving a sizeable number of 20,000 contracts. The iShares TLT tracks the price of the bond and the fact that these calls were sold today implies to us that these investors are either buying shares of TLT and taking in premium, or more likely simply taking the view that it will be hard for yields to decline much further during the next three weeks. Investors stepped in to sell around 20,000 calls at the July 96 strike for average premiums of 90 cents, implying a breakeven at 96.90. – iShares Barclays 20+ Year Treasury Bond Fund SNY – The global pharmaceutical firm’s shares have taken a major hit today, dropping more than 5% to $28.61. SNY’s third-largest-selling drug, Lantus, used in the treatment of diabetes, has been cited in medical journals that highlight the potential increased risk of cancer in those treated with the drug. Analysts at Morgan Stanley and JPMorgan reacted to the findings by lowering the stock to ‘neutral’ from ‘overweight’. A flurry of options activity launched the SNY ticker symbol onto our ‘most active by options volume’ market scanner. Investors were seen getting long of put options in both the July and August contracts. The near-term July 27.5 strike had 1,000 put options picked up for 71 cents each while the higher, deep-in-the-money July 32.5 strike price appears to have had 2,000 puts purchased for 3.75 apiece. Interestingly, a few contrarian traders were seen buying 2,500 calls at the July 30 strike for 73 cents each and another 1,000 calls at the August 30 strike for 1.42 per contract. Finally, bearishness spread to the August 27.5 strike price where another 1,000 put options were scooped up for 1.39 a-pop. Increased investor uncertainty was reflected by the rise in option implied volatility today to 44%. – Sanofi-Aventis NKE – Recent downward movement in the price of the athletic apparel designer’s shares has incited one option trader to initiate a near-term bullish reversal on the stock amid a share price decline of approximately 1% to $50.80. Perhaps anticipating further declines, the investor responsible for the reversal was seen selling 6,000 calls at the July 50 strike price for a premium of 2.21 apiece in order to fund the purchase of 6,000 puts at the same strike for 1.22 each. This individual enjoys a credit of 99 cents per contract on the trade. Further profits would amass if Nike shares were to slip below $50.00 by expiration next month. The short call position leaves this trader vulnerable to losses in the event that shares rally higher than the 99 cent buffer provided by the credit received today. He faces potentially unlimited losses above a share price of $50.99, but we’re assuming no associated stock position here. The purpose of the play might indeed be to protect against further losses to an underlying position in Nike. – Nike, Inc. TIBX– The business software company’s shares have surged higher by more than 9% today to $7.42 after the firm reported second-quarter profits which exceeded analyst expectations. TIBX appeared on our ‘hot by options volume’ market scanner following bullish activity by investors in the August contract. Optimistic option traders targeted the August 7.5 strike price where it appears that approximately 4,000 call options were coveted for an average premium of 50 cents apiece. Shares would need to climb 8% to $8.00 in order for TIBX-bulls to breakeven by expiration. Option implied volatility on the stock came off significantly following the earnings announcement to the current reading of 53% from yesterday’s closing value of 67%. – TIBCO Software, Inc. VALE – Shares of the Brazilian metals and mining company have returned some of yesterday’s gains and are currently off by approximately 1.25% to $17.85. We observed a bullish mix of options activity on the stock today by investors hoping for a recovery in Vale. The near-term July 16 strike price saw one trader buy 3,000 put options for a premium of 3.75 apiece. While such action would normally be considered bearish, the transaction appears to be linked to the purchase of an equivalent number of shares of the underlying. Perhaps wary of potential near-term declines in shares, this trader chose to pay the put premium in exchange for downside protection on the stock position. The more obvious bullish trade seen on Vale occurred at the August 19 strike, where 2,000 calls look to have been bought for an average premium of 1.05 per contract. Iron-ore optimists will begin to amass profits by expiration in August if shares rally higher by about 12% to breach the breakeven point at $20.05. – Vale S.A. ROST – With shares at the retailer finding copious amounts of support at just under $38 it would appear that one option trader is writing put premium in the expectation that he can either have shares put to him at a discount to today’s price of $38.45 or simply retain the premium. Two trades appear to have gone through that piqued our interest in early trading. The first pair of trades appear to us to be naked sales of August expiration puts at the 35 and 32.5 strikes. The seller retains the respective premiums of 40 cents and 95 cents per contract on volume of 3,000 lots. Ross’s shares dipped momentarily beneath $35 in mid-May making these look like relatively safe plays, assuming the investor likes the stock at a 9% discount to today’s price. Even then the premium at the 35 strike boosts the discount by a further 1.5%. Elsewhere we saw another 3,000 August puts at the 37.5 strike linked to 1,000 call options traded as a spread using the 40 strike. We think this investor is possibly selling puts to buy calls in the expectation of a near-term run higher on the stock. If that’s the case today, the call premium turned to a net 30 cent credit given the higher premium received on the sale of puts. – Ross Stores Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,318FansLike396,312FollowersFollow2,330SubscribersSubscribe Latest Articles Markets Mapping Trump’s connections to tech’s right-wing brotherhood Markets What brought the decline of the eastern Roman Empire – and what can we learn from it? Markets Taiwan regulators block Uber’s $950 million Foodpanda deal Energy Undersea power cable connecting Finland and Estonia experiences outage — capacity reduced to 35% as Finnish authorities investigate AI I Never Felt Like This in China Before Climate The ‘godfather of EVs’ explains why China is winning the race to go electric — and why hybrids are a ‘fool’s errand’ Market News As Santa Rally Begins, Wall Street Closes on High Note Biotech Which infectious disease is likely to be the biggest emerging problem in 2025? AI An AI system has reached human level on a test for ‘general intelligence’. Here’s what that means Markets The Testosterone Election Market News Why A Santa Claus Rally May Be Coming Markets People With Extreme Wealth Should Give It Away—or Be Penalized Markets Merry Christmas/Happy Hanukkah From PhilStockWorld! Markets Is Elon Musk a National Security Risk? (shared) Load more